Healio Dermatology

17/10/2025

💵Google Trends data reflect increased concern about the rising costs of facial cosmetic procedures after the pandemic, Vincent Pecora of The George Washington University School of Medicine & Health Sciences told Healio.

📰 Read about his analysis published in JDD - JDDonline.com.

Consumer concerns about the cost of facial cosmetic procedures have risen since the COVID-19 pandemic, according to an analysis of search engine data, a trend experts attribute to increased demand amid a transition to virtual workspaces. Between 2020 and 2021, there was a nearly 63% increase in faci...

17/10/2025

🤔 What does TrumpRx, Pfizer’s deal with the U.S. and the FDA’s regulations on pharma ads mean for Americans?

⭐ In an exclusive interview, Rachel Day, MD, FAAD, spoke with Healio about these changes.

The promise of a “TrumpRx” website to sell select prescription drugs at reduced prices to cash-paying Americans, along with the administration’s announcement of a deal with Pfizer, may not benefit many Americans, according to an expert. On Sept. 30, President Donald J. Trump announ...

16/10/2025

✍️ GLP-1 receptor agonist therapy reduced the following complications among people with hidradenitis suppurativa:
📉 Surgical abscess repairs
📉 Hospitalizations

Researchers from SUNY Downstate discussed these findings ⬇️

https://www.healio.com/news/dermatology/20251016/glp1-receptor-agonists-may-reduce-hidradenitis-suppurativa-surgeries-hospitalizations

Endocrine Today

GLP-1 receptor agonist therapy reduced surgical abscess repairs and hospitalizations among people with hidradenitis suppurativa, regardless of type 2 diabetes status, according to a study.“HS is a debilitating disease that often requires repeated surgeries and hospitalizations, yet current tre...

15/10/2025

💻An analysis of search engine data published in JDD - JDDonline.com suggest a substantial ⬆️ in cost concerns post-pandemic related to noninvasive procedures like injectable fillers and .

🗣️ Healio spoke with incent Pecora of The George Washington University School of Medicine & Health Sciences about the trend.

Consumer concerns about the cost of facial cosmetic procedures have risen since the COVID-19 pandemic, according to an analysis of search engine data, a trend experts attribute to increased demand amid a transition to virtual workspaces. Between 2020 and 2021, there was a nearly 63% increase in faci...

15/10/2025

Because your time matters. ⏳ Tap in to manage CME the easy way.

Download Now: http://bit.ly/4oKfmYW

14/10/2025

💊 Never second guess a prescribing decision again. Healio’s Drug Lookup puts dosing, indications and safety info at your fingertips.

Try it now 👉 https://www.healio.com/clinical-guidance/drugs

13/10/2025

🔎 Linda Stein Gold, MD, of Henry Ford Health, discussed the latest results from ICONIC-ADVANCE 1 and 2, comparing icotrokinra to deucravacitinib for .

https://www.healio.com/news/dermatology/20251009/icotrokinra-treatment-outperformed-deucravacitinib-for-plaque-psoriasis

EADV - European Academy of Dermatology and Venereology Johnson & Johnson

Icotrokinra demonstrated superiority to placebo and deucravacitinib in the treatment of adults and adolescents with moderate to severe plaque psoriasis, according to two studies. Part of the ICONIC program, the ICONIC-ADVANCE 1 and 2 studies are phase 3 trials that evaluated the efficacy and safety....

10/10/2025

📢 “Be aware that hair transplantation can help restore a natural frame of hair for women just like it can with men,” Mark Avram, MD, told Healio.

📰Read more about his JDD - JDDonline.com analysis on hair transplantation in Healio.

Women with androgenic alopecia and other forms of hair loss can derive meaningful benefits from a combination of follicle transplantation and adjunctive medical management, yet many people remain unaware that transplant is an option.“Hair loss affects anyone negatively, but especially women,&r...

09/10/2025

🔎 Lawrence F. Eichenfield, MD, of Rady Children's Hospital-San Diego, discussed the studies that supported the U.S. Food and Drug Administration’s approval of Zoryve cream 0.05% for pediatric atopic dermatitis.

https://www.healio.com/news/dermatology/20251006/fda-approves-zoryve-cream-005-for-pediatric-atopic-dermatitis

Healio Allergy & Asthma Healio Pediatrics

09/10/2025

🔎 Ulrich Mrowietz, MD discussed findings from the POSITIVE study with Healio, which evaluated the well-being and mental health of people receiving long-term treatment for moderate to severe psoriasis.

https://www.healio.com/news/dermatology/20251007/psychological-well-being-improved-with-psoriasis-clearance

EADV - European Academy of Dermatology and Venereology Healio Psychiatry

09/10/2025

💊 Icotrokinra outperformed placebo and deucravacitinib, according to new 24-week results.

🔑 Proportion of participants reaching IGA 0/1 in ICONIC-ADVANCE 1 & 2:
- Icotrokinra = 74% and 68%
- Deucravacitinib = 52% and 55%

https://www.healio.com/news/dermatology/20251009/icotrokinra-treatment-outperformed-deucravacitinib-for-plaque-psoriasis

EADV - European Academy of Dermatology and Venereology

Icotrokinra demonstrated superiority to placebo and deucravacitinib in the treatment of adults and adolescents with moderate to severe plaque psoriasis, according to two studies. Part of the ICONIC program, the ICONIC-ADVANCE 1 and 2 studies are phase 3 trials that evaluated the efficacy and safety....

08/10/2025

💡Having successful PAs and NPs at your clinic requires:

- Identify what is within scope of practice
- Communicating
- Mentoring

Read more about how to achieve this goal with tips from Healio’s latest exclusive ⬇️

https://www.healio.com/news/dermatology/20251002/how-to-establish-clear-roles-collaborate-with-advanced-practice-providers